GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Earnings per Share (Diluted)

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Earnings per Share (Diluted) : $-0.01 (TTM As of Mar. 2017)


View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Earnings per Share (Diluted)?

Aoxing Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Mar. 2017 was $0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.01.

Aoxing Pharmaceutical Co's EPS (Basic) for the three months ended in Mar. 2017 was $0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.01.

Aoxing Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2017 was $0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.02.


Aoxing Pharmaceutical Co Earnings per Share (Diluted) Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co Earnings per Share (Diluted) Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.32 -0.34 -0.16 0.09 0.03

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.02 0.01 - -

Competitive Comparison of Aoxing Pharmaceutical Co's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aoxing Pharmaceutical Co's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's PE Ratio falls into.



Aoxing Pharmaceutical Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Aoxing Pharmaceutical Co's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2016 is calculated as

Diluted Earnings Per Share (A: Jun. 2016 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(2.061-0)/75.468
=0.03

Aoxing Pharmaceutical Co's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2017 is calculated as

Diluted Earnings Per Share (Q: Mar. 2017 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(0.132-0)/76.209
=0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Aoxing Pharmaceutical Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.
Executives
Wilfred Chow officer: Chief Financial Officer 30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea director C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo director, officer: Secretary 80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines